Last updated: 2016-08-18
Content Responsible: sravan (
sravan@accomplice.se)
A review article focusing on the Drug Discovery and Development platform has been published in Drug Discovery Today. The article describes the origin of the platform as well as it’s purpose and structure.
Highlights
- SciLifeLab DDD platform reaches out to Swedish academia with an industry-standard infrastructure for academic drug discovery.
- The Swedish Teacher Exemption Law, an internationally unique aspect of the innovation system, has shaped the operation.
- SciLifeLab DDD facilitates international collaboration between academia and industry.
Read the full review: doi:10.1016/j.drudis.2016.06.026